| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/21/2010 | US20100015104 Generation of adipose tissue and adipocytes |
| 01/21/2010 | US20100015086 Use of il-22 for the treatment of conditions of metabolic disorders |
| 01/21/2010 | DE102006052560B4 Anti-diabetogene Calcium-Peptid-Zusammensetzung Anti-diabetogenic calcium peptide composition |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2849218A1 Compositions and methods for treating disorders associated with overweight animals |
| 01/21/2010 | CA2739379A1 Compounds as the estrogen-related receptor modulators and the uses thereof |
| 01/21/2010 | CA2731097A1 Organic compounds |
| 01/21/2010 | CA2731020A1 Methods of treating an overweight or obese subject |
| 01/21/2010 | CA2730964A1 Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors |
| 01/21/2010 | CA2730959A1 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | CA2730958A1 Novel sulphur containing lipids for use as food supplement or as medicament |
| 01/21/2010 | CA2730931A1 Solid forms of (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol and methods of their use |
| 01/21/2010 | CA2730929A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 01/21/2010 | CA2730843A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/21/2010 | CA2730753A1 Large-scale process for the preparation of thylakoids |
| 01/21/2010 | CA2730734A1 Deuterated benzylbenzene derivatives and methods of use |
| 01/21/2010 | CA2730610A1 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 01/21/2010 | CA2730606A1 Bicyclic heterocycle derivatives and methods of use thereof |
| 01/21/2010 | CA2730593A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 01/21/2010 | CA2730493A1 Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2730059A1 Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetes |
| 01/21/2010 | CA2729909A1 Imidazolyl pyrimidine inhibitor compounds |
| 01/21/2010 | CA2729212A1 Compounds and methods for modulating g protein-coupled receptors |
| 01/21/2010 | CA2727174A1 Aryl gpr119 agonists and uses thereof |
| 01/20/2010 | EP2145884A1 Indoledione derivative |
| 01/20/2010 | EP2145615A1 Skin-lightening agent containing equol compound as active ingredient |
| 01/20/2010 | EP2144902A1 [6,6]and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 01/20/2010 | EP2144885A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors |
| 01/20/2010 | EP1827415B1 Cyclopropane acid derivatives for the reduction of lipid levels |
| 01/20/2010 | EP1758853B1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 01/20/2010 | EP1663191B1 Composition comprising rosiglitazone and metformin |
| 01/20/2010 | EP1654247B1 Alkynyl aryl carboxamides |
| 01/20/2010 | EP1615647B1 Pharmaceutical use of fused 1,2,4-triazoles |
| 01/20/2010 | EP1490333B1 New atorvastatin salts and pharmaceutical compositions containing them |
| 01/20/2010 | EP1474114B1 Oral dosage form for controlled drug release |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1427396B1 Dosage forms having prolonged active ingredient release |
| 01/20/2010 | EP1338603B1 Novel pyrazole derivatives and diabetes remedies containing the same |
| 01/20/2010 | EP1077994B1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 01/20/2010 | CN101628905A C-aryl glucoside SGLT2 inhibitors and method |
| 01/20/2010 | CN101627991A Endurance improving agent |
| 01/20/2010 | CN100582116C Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof |
| 01/20/2010 | CN100582104C Oxadiazolone derivatives as PPAR delta agonists |
| 01/20/2010 | CN100582098C Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (P T P 1 B) inhibitors for using as blood-sugar decreasing active ingredients for treating |
| 01/20/2010 | CN100582088C Aminoalcohol derivatives |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/20/2010 | CN100581562C Preparation method for separating and purifying extractive from lotus leaves, and usage |
| 01/20/2010 | CN100581554C Abalone shell calcium complement agent |
| 01/20/2010 | CN100581551C Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS) |
| 01/20/2010 | CN100581390C Soup material for Hot-pot |
| 01/20/2010 | CN100581374C Waxberry tea and its preparation method |
| 01/19/2010 | US7649097 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7649012 Compounds, pharmaceutical compositions containing same, and methods of use for same |
| 01/19/2010 | US7648999 Activator for peroxisome proliferator-activated receptor δ |
| 01/19/2010 | US7648979 5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives |
| 01/19/2010 | US7648960 Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles |
| 01/19/2010 | US7648959 Methods and compositions for the treatment of diseases of the eye |
| 01/19/2010 | US7648957 Comprising a peptide fraction which is preferably rich in di- and tripeptides in combination with an insulin sensitizer, preferably a natural or pharmaceutical insulin sensitizer; suitable as pharmaceutical or food or a food supplement; especially useful for Type 2 diabetes |
| 01/19/2010 | US7648710 Formulation containing phosphate derivatives of electron transfer agents |
| 01/19/2010 | US7648677 Method for operating a reservoir-based sensor device |
| 01/19/2010 | CA2427660C Biphenylcarboxamides useful as lipid lowering agents |
| 01/19/2010 | CA2420026C 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 01/19/2010 | CA2373255C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 01/19/2010 | CA2373093C Methods and compounds for inhibiting amyloid deposits |
| 01/19/2010 | CA2353805C Use of phytanic acid for the treatment of diabetes |
| 01/19/2010 | CA2335107C Leptin-mediated gene-induction |
| 01/19/2010 | CA2319640C Electrochemically reactive cathodes for an electrotransport device |
| 01/17/2010 | CA2653883A1 High fructan cereal plants |
| 01/15/2010 | CA2637977A1 Dosage form containing a statin |
| 01/14/2010 | WO2010006191A1 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 01/14/2010 | WO2010006172A2 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | WO2010006169A2 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs |
| 01/14/2010 | WO2010006135A2 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 01/14/2010 | WO2010006125A2 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 01/14/2010 | WO2010006123A2 19-nor-vitamin d analogs with 1,2-dihydrofuran ring |
| 01/14/2010 | WO2010006121A2 19-nor-vitamin d analogs with 3,2-dihydrofuran ring |
| 01/14/2010 | WO2010005961A2 Nutritive compositions and methods of using same |
| 01/14/2010 | WO2010005565A2 Method of treating glycogen storage disease |
| 01/14/2010 | WO2010004982A1 Ameliorating or therapeutic agent for dyslipidemia |
| 01/14/2010 | WO2010004972A1 Nitrogen-containing aromatic heterocyclyl compound |
| 01/14/2010 | WO2010004916A1 Hypoglycemic agent, and food or beverage for prevention of diabetes or amelioration of condition of diabetes comprising same |
| 01/14/2010 | WO2010004857A1 Body fat accumulation inhibitor and food/beverage containing same |
| 01/14/2010 | WO2010004348A1 Heterocyclic gpcr agonists |
| 01/14/2010 | WO2010004347A1 Heterocyclic gpcr agonists |
| 01/14/2010 | WO2010004346A1 Piperidinyl gpcr agonists |
| 01/14/2010 | WO2010004345A1 Piperidinyl gpcr agonists |
| 01/14/2010 | WO2010004344A1 Piperidine gpcr agonists |
| 01/14/2010 | WO2010004343A1 Piperidinyl gpcr agonists |
| 01/14/2010 | WO2010003939A1 Use of pasireotide for the treatment of endogenous hyperinsulinemic hypoglycemia |
| 01/14/2010 | WO2010003624A2 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 01/14/2010 | WO2010003350A1 1-substituted pyridyl-pyrazolyl amide compounds and uses thereof |
| 01/14/2010 | WO2010003240A1 Gmcsf and truncated ccl2 conjugates and methods and uses thereof |
| 01/14/2010 | WO2009109973A3 Compounds and methods of treating obesity |
| 01/14/2010 | WO2009098490A4 Antimicrobial agents for the treatment of campylobacter species in the crop of a bird |
| 01/14/2010 | US20100010074 Inhibiting Serum Response Factor (SRF) to Improve Glycemic Control |
| 01/14/2010 | US20100010068 Liver-directed gene therapy |
| 01/14/2010 | US20100010061 Cb1 receptor modulators |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |